In the last trading session, 2.16 million Solid Biosciences Inc (NASDAQ:SLDB) shares changed hands as the company’s beta touched 2.12. With the company’s per share price at $5.78 changed hands at -$0.22 or -3.67% during last session, the market valuation stood at $441.12M. SLDB’s last price was a discount, traded about -160.38% off its 52-week high of $15.05. The share price had its 52-week low at $2.88, which suggests the last value was 50.17% up since then.
Analysts gave the Solid Biosciences Inc (SLDB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.08. If we narrow down to specifics, the data shows that 0 out of 6 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SLDB as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight. Solid Biosciences Inc’s EPS for the current quarter is expected to be -0.78.
Solid Biosciences Inc (NASDAQ:SLDB) trade information
Instantly SLDB was in red as seen at the end of in last trading. With action 46.70%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 44.50%, with the 5-day performance at 46.70% in the green. However, in the 30-day time frame, Solid Biosciences Inc (NASDAQ:SLDB) is 85.26% up.
The consensus price target for the stock as assigned by Wall Street analysts is 19, meaning bulls need an upside of 69.58% from its current market value. According to analyst projections, SLDB’s forecast low is 12 with 20 as the target high. To hit the forecast high, the stock’s price needs a -246.02% plunge from its current level, while the stock would need to soar -107.61% for it to hit the projected low.
Solid Biosciences Inc (SLDB) estimates and forecasts
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 32.21%. The 2025 estimates are for Solid Biosciences Inc earnings to increase by 39.19%, but the outlook for the next 5-year period is at 18.10% per year.
Solid Biosciences Inc (NASDAQ:SLDB)’s Major holders
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. With 854.68 shares estimated at $4.94 million under it, the former controlled 1.12% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 0.85% of the shares, roughly 650.02 shares worth around $3.76 million.
